top of page
Search Results

249 items found for "homology modeling"

  • AlphaFold2 versus experimental structures: evaluation on G protein-coupled receptors

    Recently, AlphaFold2 has been developed to predict structure models of many functionally important proteins Herein we evaluated the accuracy of GPCR structure models predicted by AlphaFold2. However, the predicted models and experimental structures were different in many aspects including the These differences impeded the use of predicted structure models in the functional study and structure-based

  • 📰 GPCR Weekly News, January 23 to 29, 2023

    Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex. into GPCR Function Structural and dynamic insights into supra-physiological activation and allosteric modulation

  • 📰 GPCR Weekly News, February 5 to 11, 2024

    , 2024 GPCR Activation and Signaling Constitutive activation mechanism of a class C GPCR Allosteric modulation Research GPCR-BERT: Interpreting Sequential Design of G Protein-Coupled Receptors Using Protein Language Models Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models

  • 📰 GPCR Weekly News

    Biased agonists differentially modulate the receptor conformation ensembles in Angiotensin II type 1 Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders Characterization of a novel positive allosteric modulator of the α1A-Adrenergic receptor. Lipid Modulation of a Class B GPCR: Elucidating the Modulatory Role of PI(4,5)P2 Lipids. Evaluating GPCR modeling and docking strategies in the era of deep learning-based protein structure prediction

  • 📰 GPCR Weekly News, January 8 to 14, 2024

    GPCRs in Neuroscience The Na+ leak channel NALCN controls spontaneous activity and mediates synaptic modulation learning Industry News Exscientia Unveils MolFlux: Empowering the ML Community in Molecular Predictive Modelling Executive Officer Unraveling GPCRs Conformations: A Leap in Drug Discovery with STAGS Machine Learning Model

  • Arginine 125 Is an Essential Residue for the Function of MRAP2

    September 2022 "MRAP2 is a small simple transmembrane protein arranged in a double antiparallel topology

  • 📰 GPCR Weekly News, November 6 to November 12, 2023

    promotes autistic-like behavior Acetate mitigates cardiac mitochondrial dysfunction in experimental model of polycystic ovarian syndrome by modulating GPCR41/43 and PROKR1 GPCRs in Neuroscience Diverse signaling Industry News Exscientia Business Update for Third Quarter 2023 Addex CEO Tim Dyer to Discuss Allosteric Modulators

  • 📰 GPCR Weekly News, April 22 to 28, 2024

    Signaling at the Endosome GPCR Binders, Drugs, and more Discovery and development of macrocyclic peptide modulators RNA NEAT1 in Alzheimer's disease Parenting behaviors in mice: Olfactory mechanisms and features in models Generation of a deep mouse brain spectral library for transmembrane proteome profiling in mental disease models

  • Endosomal parathyroid hormone receptor signaling

    October 2022 "The canonical model for G protein-coupled receptors (GPCRs) activation assumes that stimulation In this model, GPCR signaling is turned-off by receptor phosphorylation via GPCR kinases (GRKs) and subsequent However, over the last decade, this model has been extended by discovering that some internalized GPCRs

  • 📰 GPCR Weekly News, January 1 to 7, 2024

    ortholog MRGPRB2 Metabolite-sensing GPCRs in rheumatoid arthritis Dissecting the molecular basis for the modulation protein-coupled receptor Methods & Updates in GPCR Research RediscMol: Benchmarking Molecular Generation Models leucine and isoleucine in tuning the hydropathy of class A GPCRs Arylsulfatases and neuraminidases modulate

  • 📰 GPCR Weekly News, January 15 to 21, 2024

    Graham Ladds’ team refines AlphaFold models using binding calculations for human adenosine A3 receptor islets regulating somatostatin release and islet development GPCR Activation and Signaling In Vitro Module activation and signaling GPCR Binders, Drugs, and more Computational Workflow for Refining AlphaFold Models

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    GPCR Binders, Drugs, and more Allosteric modulator potentiates β2AR agonist-promoted bronchoprotection in asthma models.

  • C5aR2 receptor: The genomic twin of the flamboyant C5aR1

    The current study has attempted to close the gap by generating highly refined model structures of C5aR2 inactive), complexed to C-terminal peptide of C5a (meta-active) and the C5a (active), embedded to a model The computational modeling and the 1.5-μs molecular dynamics data presented in the current study are

  • 📰 GPCR Weekly News

    Dynamic spatiotemporal determinants modulate GPCR:G protein coupling selectivity and promiscuity. Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs A quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson's

  • Angiotensin-(1-7) improves cognitive function and reduces inflammation in mice following mild trauma

    This study examined the therapeutic effect of Ang-(1-7) on secondary injury observed in a murine model of mild TBI (mTBI) in a closed skull, single injury model."

  • 📰 GPCR Weekly News, June 3 to June 9, 2024

    factor-dependent phosphorylation of Gαi shapes canonical signaling by G protein-coupled receptors Kinetic Model cells GPCR Binders, Drugs, and more Structure-based identification of a G protein-biased allosteric modulator

  • 📰 GPCR Weekly News, April 1 to 7, 2024

    Brake for Airway Smooth Muscle Cell Movement Hepatic extracellular ATP/adenosine dynamics in zebrafish models receptor signaling in humoral immunity Industry News Neurosterix launches with $63M to Advance Allosteric Modulator

  • HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle

    Arrb1 deficiency suppressed HBx-induced hepatocellular carcinogenesis in several mouse models. Our results demonstrate that ARRB1 plays a critical role in HBV-related HCC via modulating autophagy

  • 📰 GPCR Weekly News, March 4 to 10, 2024

    Receptors GPCRs in Neuroscience A M1 muscarinic acetylcholine receptor-specific positive allosteric modulator Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function Interaction modes spectroscopy Up-regulation of GPR139 in the medial septum ameliorates cognitive impairment in two mouse models

  • Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or sy

    Methods: Using a widely adopted rodent model of 3-day recurrent hypoglycemia, we first checked expression The abovementioned studies were repeated in streptozotocin-induced diabetic rat model.

  • Glyco-sulfo hotspots in the chemokine receptor system

    chemokine receptors with their cognate chemokine ligands is generally described by the two-step/two-site model Within the CRS1 ineraction mode, the N-terminal region of chemokine receptors is indispensable for chemokine Probing the modulation of O-glycosylation and tyrosine sulfation on CCR5 and CCR1 function In this study mutagenesis approaches were performed to evaluate the effects of O-glycosylation and tyrosine sulfation modulation It remains to be discovered how much the modulation of these PTMs is relevant for future drug design.

  • Targeting Intracellular Allosteric Sites in GPCRs

    Unlike orthosteric ligands that bind directly to the receptor's active site, allosteric modulators target Over the past decade, there has been a notable growth in the discovery of allosteric modulators for GPCRs functional and/or affinity for an orthosteric ligand; and negative allosteric modulators (NAMs), that In this context, allosteric modulators exhibiting constrained positive or negative cooperativity are SBI-553, an allosteric modulator of NTSR1, provides valuable insights into how allosteric modulation

  • 📰 GPCR Weekly News, July 24 to July 30, 2023

    GPCR Symposium on GPCRs as Therapeutic Modalities is on September 22nd. Structural and Molecular Insights into GPCR Function Ternary model structural complex of C5a, C5aR2,

  • 📰 GPCR Weekly News, September 18 to 24, 2023

    GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it! functional survival of human islets AT2 receptor agonist LP2 restores respiratory function in a rat model

  • 📰 GPCR Weekly News, March 6 to 12, 2023

    Neuroscience Quinpirole ameliorates nigral dopaminergic neuron damage in Parkinson's disease mouse model Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization modulates

  • 📰 GPCR Weekly News, February 26 to March 3, 2024

    acid substitution G protein-coupled receptors: from radioligand binding to cellular signaling GPR101: Modeling potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach Opioid modulation

  • Chemokine receptor-targeted drug discovery: progress and challenges

    receptors can homo- and hetero-oligomerize, impacting receptor/ligand-binding and signaling patterns, by modulating These larger interfaces represent the typical protein-protein interactions which are difficult to modulate Overall, the future potential lies in using different therapeutic modalities to modulate the stromal

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    Establishment of a CaCC-based Cell Model and Method for High-throughput Screening of M3 Receptor Drugs FSHR activation through small molecule modulators: Mechanistic insights from MD simulations. Structural and Molecular Insights into GPCR Function The activation mechanism and antibody binding mode

bottom of page